Pharmicell Co Ltd
KRX:005690

Watchlist Manager
Pharmicell Co Ltd Logo
Pharmicell Co Ltd
KRX:005690
Watchlist
Price: 13 750 KRW 4.09% Market Closed
Market Cap: ₩825.3B

Net Margin

28.5%
Current
Improving
by 16.4%
vs 3-y average of 12.1%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
28.5%
=
Net Income
₩28.8B
/
Revenue
₩100.9B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
28.5%
=
Net Income
₩28.8B
/
Revenue
₩100.9B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Pharmicell Co Ltd
KRX:005690
825.1B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
385B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.4B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
169B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.3B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.1B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.8B USD
Loading...

Market Distribution

Higher than 95% of companies in Korea
Percentile
95th
Based on 2 632 companies
95th percentile
28.5%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Pharmicell Co Ltd
Glance View

Market Cap
825.3B KRW
Industry
Biotechnology

Pharmicell Co., Ltd. is engaged in the development of stem cell based pharmaceuticals and technologies. The company is headquartered in Seoul, Seoul and currently employs 127 full-time employees. Its biopharmaceutical business engages in the development and manufacture of stem cell therapeutic drugs and stem cell-based cosmetics and others. The company also provides steam cell storage services, and mesenchymal stem cells (MSCs) used for research areas and others. In addition, the Company engages in the fashion business, which provides women’s and men’s apparels under the brand names of Religion and Day. On March 31, 2013, the Company merged with its wholly owned subsidiary, mainly engaged in the manufacture and sale of medicines.

Pharmicell Co Ltd Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
28.5%
=
Net Income
₩28.8B
/
Revenue
₩100.9B
What is Pharmicell Co Ltd's current Net Margin?

The current Net Margin for Pharmicell Co Ltd is 28.5%, which is above its 3-year median of 12.1%.

How has Net Margin changed over time?

Over the last 3 years, Pharmicell Co Ltd’s Net Margin has increased from 21.5% to 28.5%. During this period, it reached a low of 2.8% on Mar 31, 2024 and a high of 28.5% on Sep 30, 2025.

Back to Top